Abstract
The new β2 Adrenoceptor (β2AR) crystal structures provide a high-resolution snapshot of receptor interactions with two particular partial inverse agonists, (−)-carazolol and timolol. However, both experimental and computational studies of GPCR structure are significantly complicated by the existence of multiple conformational states coupled to ligand type and receptor activity. Agonists and antagonists induce or stabilize distinct changes in receptor structure that mediate a range of pharmacological activities. In this work, we (1) established that the existing β2AR crystallographic conformers can be extended to describe ligand/receptor interactions for additional antagonist types, (2) generated agonist-bound receptor conformations, and (3) validated these models for agonist and antagonist virtual ligand screening (VLS). Using a ligand directed refinement protocol, we derived a single agonist-bound receptor conformation that selectively retrieved a diverse set of full and partial β2AR agonists in VLS trials. Additionally, the impact of extracellular loop two conformation on VLS was assessed by docking studies with rhodopsin-based β2AR homology models, and loop-deleted receptor models. A general strategy for constructing and selecting agonist-bound receptor pocket conformations is presented, which may prove broadly useful in creating agonist and antagonist bound models for other GPCRs.
Similar content being viewed by others
References
Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Trong IL, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M (2000) Science 289:739. doi:10.1126/science.289.5480.739
Park JH, Scheerer P, Hofmann KP, Choe H–W, Ernst OP (2008) Nature 454:183–187. doi:10.1038/nature07063
Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG, Schertler GF (2008) Nature 454:486–491. doi:10.1038/nature07101
Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS, Choi H-J, Kuhn P, Weis WI, Kobilka BK, Stevens RC (2007) Science 318:1258. doi:10.1126/science.1150577
Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola V-P, Chien EYT, Velasquez J, Kuhn P, Stevens RC (2008) Structure 16:897. doi:10.1016/j.str.2008.05.001
Kenakin T (2003) Trends Pharmacol Sci 24:346. doi:10.1016/S0165-6147(03)00167-6
Kobilka BK, Deupi X (2007) Trends Pharmacol Sci 28:397. doi:10.1016/j.tips.2007.06.003
Urban JD, Clarke WP, von Zastrow M, Nichols DE, Kobilka B, Weinstein H, Javitch JA, Roth BL, Christopoulos A, Sexton PM, Miller KJ, Spedding M, Mailman RB (2007) J Pharmacol Exp Ther 320:1. doi:10.1124/jpet.106.104463
Schwartz TW, Frimurer TM, Holst B, Rosenkilde MM, Elling CE (2006) Annu Rev Pharmacol Toxicol 46:481. doi:10.1146/annurev.pharmtox.46.120604.141218
Bottegoni G, Kufareva I, Totrov M, Abagyan R (2008) J Comput Aided Mol Des 22:311. doi:10.1007/s10822-008-9188-5
Bissantz C, Bernard P, Hibert M, Rognan D (2003) Proteins 50:5. doi:10.1002/prot.10237
Ballesteros JA, Weinstein H (1995) Methods Neurosci 25:366. doi:10.1016/S1043-9471(05)80049-7
Rasmussen SGF, Choi H-J, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VRP, Sanishvili R, Fischetti RF, Schertler GFX, Weis WI, Kobilka BK (2007) Nature 450:383. doi:10.1038/nature06325
Rosenbaum DM, Cherezov V, Hanson MA, Rasmussen SGF, Thian FS, Kobilka TS, Choi H-J, Yao X-J, Weis WI, Stevens RC, Kobilka BK (2007) Science 318:1266. doi:10.1126/science.1150609
Bhattacharya S, Hall SE, Li H, Vaidehi N (2008) Biophys J 94:2027. doi:10.1529/biophysj.107.117648
Gouldson PR, Kidley NJ, Bywater RP, Psaroudakis G, Brooks HD, Diaz C, Shire D, Reynolds CA (2004) Proteins 56:67. doi:10.1002/prot.20108
Bisson WH, Cheltsov AV, Bruey-Sedano N, Lin B, Chen J, Goldberger N, May LT, Christopoulos A, Dalton JT, Sexton PM, Zhang X-K, Abagyan R (2007) Proc Natl Acad Sci USA 104:11927. doi:10.1073/pnas.0609752104
Cavasotto CN, Orry AJW, Murgolo NJ, Czarniecki MF, Kocsi SA, Hawes BE, O’Neill KA, Hine H, Burton MS, Voigt JH, Abagyan RA, Bayne ML, Monsma FJ (2008) J Med Chem 51:581. doi:10.1021/jm070759m
Mehler EL, Hassan SA, Kortagere S, Weinstein H (2006) Proteins. Struct Funct Bioinformatics 64:673. doi:10.1002/prot.21022
Kortagere S, Roy A, Mehler E (2006) J Comput Aided Mol Des 20:427. doi:10.1007/s10822-006-9056-0
Abagyan R, Totrov M (1994) J Mol Biol 235:983. doi:10.1006/jmbi.1994.1052
Nemethy G, Gibson KD, Palmer KA, Yoon CN, Paterlini G, Zagari A, Rumsey S, Scheraga HA (1992) J Phys Chem 96:6472. doi:10.1021/j100194a068
Halgren TA (1996) J Comput Chem 17:490. doi:10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
Raffa RB (ed) (2001) Drug-receptor thermodynamics introduction and applications. Wiley-VCH, NewYork
Totrov M (2008) Chem Biol Drug Des 71:15
Abagyan RA, Batalov S (1997) J Mol Biol 273:355. doi:10.1006/jmbi.1997.1287
Totrov M, Abagyan R (1997) Proteins Suppl 1:215. doi:10.1002/(SICI)1097-0134(1997)1+<215::AID-PROT29>3.0.CO;2-Q
Okuno Y, Tamon A, Yabuuchi H, Niijima S, Minowa Y, Tonomura K, Kunimoto R, Feng C (2008) Nucleic Acids Res 36:D907. doi:10.1093/nar/gkm948
Guha R, Howard MT, Hutchison GR, Murray-Rust P, Rzepa H, Steinbeck C, Wegner J, Willighagen EL (2006) J Chem Inf Model 46:991. doi:10.1021/ci050400b
Topiol S, Sabio M (2008) Bioorg Med Chem Lett 18:1598. doi:10.1016/j.bmcl.2008.01.063
Bissantz C, Wolfgang CS, Stahl GM (2005) Proteins. Struct Funct Bioinformatics 61:938. doi:10.1002/prot.20651
Chen JZ, Wang J, Xie XQ (2007) J Chem Inf Model 47:1626. doi:10.1021/ci7000814
Evers A, Hessler G, Matter H, Klabunde T (2005) J Med Chem 48:5448. doi:10.1021/jm050090o
Evers A, Klabunde T (2005) J Med Chem 48:1088. doi:10.1021/jm0491804
Krystek SR, Kimura SR, Tebben AJ, Langley DR (2006) J Comput Aided Mol Des 20:463. doi:10.1007/s10822-006-9065-z
Kimura SR, Tebben AJ, Langley DR (2008) Proteins. Struct Funct Bioinformatics 71:1919–1929. doi:10.1002/prot.21906
Patny A, Desai PV, Avery MA (2006) Proteins. Struct Funct Bioinformatics 65:824. doi:10.1002/prot.21196
Varady J, Wu X, Fang X, Min J, Hu Z, Levant B, Wang S (2003) J Med Chem 46:4377. doi:10.1021/jm030085p
Costanzi S (2008) J Med Chem 51:2907–2914. doi:10.1021/jm800044k
Strader CD, Candelore MR, Hill WS, Sigal IS, Dixon RA (1989) J Biol Chem 264:13572
Liapakis G, Ballesteros JA, Papachristou S, Chan WC, Chen X, Javitch JA (2000) J Biol Chem 275:37779. doi:10.1074/jbc.M002092200
Avlani VA, Gregory KJ, Morton CJ, Parker MW, Sexton PM, Christopoulos A (2007) J Biol Chem 282:25677. doi:10.1074/jbc.M702311200
Shi L, Javitch JA (2004) Proc Natl Acad Sci USA 101:440. doi:10.1073/pnas.2237265100
de Graaf C, Foata N, Engkvist O, Rognan D (2008) Proteins. Struct Funct Bioinformatics 71:599. doi:10.1002/prot.21724
Ghanouni P, Gryczynski Z, Steenhuis JJ, Lee TW, Farrens DL, Lakowicz JR, Kobilka BK (2001) J Biol Chem 276:24433. doi:10.1074/jbc.C100162200
de Graaf C, Rognan D (2008) J Med Chem 51:4978. doi:10.1021/jm800710x
Acknowledgments
K.A.R. and R.A. gratefully acknowledge support from the National Institutes of Health (GM074832).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Following files are unfortunately not in the Publisher's archive anymore:
-
(PDB 355 kb)
-
(PDB 560 kb)
Rights and permissions
About this article
Cite this article
Reynolds, K.A., Katritch, V. & Abagyan, R. Identifying conformational changes of the β2 adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators. J Comput Aided Mol Des 23, 273–288 (2009). https://doi.org/10.1007/s10822-008-9257-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-008-9257-9